Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy.
Cesani M, Lorioli L, Grossi S, Amico G, Fumagalli F, Spiga I, Filocamo M, Biffi A.
Hum Mutat. 2016 Jan;37(1):16-27. doi: 10.1002/humu.22919. Epub 2015 Nov 4.
Atidarsagene autotemcel for metachromatic leukodystrophy.
Messina M, Gissen P.
Drugs Today (Barc). 2023 Feb;59(2):63-70. doi: 10.1358/dot.2023.59.2.3461911.
Metachromatic leukodystrophy--an update.
Gieselmann V, Krägeloh-Mann I.
Neuropediatrics. 2010 Feb;41(1):1-6. doi: 10.1055/s-0030-1253412. Epub 2010 Jun 22.
Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix.
Trinidad M, Hong X, Froelich S, Daiker J, Sacco J, Nguyen HP, Campagna M, Suhr D, Suhr T, LeBowitz JH, Gelb MH, Clark WT.
Genome Biol. 2023 Jul 21;24(1):172. doi: 10.1186/s13059-023-03001-z.
Metachromatic leukodystrophy: A story of hope woven from sorrow.
Adang L.
Mol Ther. 2024 May 1;32(5):1179. doi: 10.1016/j.ymthe.2024.04.008. Epub 2024 Apr 16.
Metachromatic leukodystrophy: Disease spectrum and approaches for treatment.
van Rappard DF, Boelens JJ, Wolf NI.
Best Pract Res Clin Endocrinol Metab. 2015 Mar;29(2):261-73. doi: 10.1016/j.beem.2014.10.001. Epub 2014 Oct 16.
Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective.
Beerepoot S, Nierkens S, Boelens JJ, Lindemans C, Bugiani M, Wolf NI.
Orphanet J Rare Dis. 2019 Nov 4;14(1):240. doi: 10.1186/s13023-019-1220-4.
Gene therapy for metachromatic leukodystrophy.
Rosenberg JB, Kaminsky SM, Aubourg P, Crystal RG, Sondhi D.
J Neurosci Res. 2016 Nov;94(11):1169-79. doi: 10.1002/jnr.23792.
Metachromatic leukodystrophy: recent research developments.
Gieselmann V.
J Child Neurol. 2003 Sep;18(9):591-4. doi: 10.1177/08830738030180090301.
Gallbladder Polyps in Metachromatic Leukodystrophy.
Almarzooqi S, Quadri A, Albawardi A.
Fetal Pediatr Pathol. 2018 Apr;37(2):102-108. doi: 10.1080/15513815.2018.1424277. Epub 2018 Mar 1.
